Establishment of canine hemangiosarcoma xenograft models expressing endothelial growth factors, their receptors, and angiogenesis-associated homeobox genes

BMC Cancer

Volumn 9, Issue , 2009, Pages 363-

  Kodama, Atsushi ^a,c   Sakai, Hiroki ^a   Matsuura, Satoko ^a   Murakami, Mami ^a   Murai, Atsuko ^a   Mori, Takashi ^a   Maruo, Kouji ^a   Kimura, Tohru ^b   Masegi, Toshiaki ^a   Yanai, Tokuma ^a  

^a GIFU UNIVERSITY   (Japan)

^b NATIONAL INSTITUTES OF NATURAL SCIENCES   (Japan)

^c JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; CD31 ANTIGEN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; HOMEODOMAIN PROTEIN; TRANSCRIPTION FACTOR HOXA9; TRANSCRIPTION FACTOR HOXB3; TRANSCRIPTION FACTOR HOXB7; TRANSCRIPTION FACTOR HOXD3; TRANSCRIPTION FACTOR MEIS1; TRANSCRIPTION FACTOR PBX1; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VON WILLEBRAND FACTOR;

ANGIOSARCOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREED DIFFERENCE; CANCER CELL; CANCER TRANSPLANTATION; CELL PROLIFERATION; CELL SHAPE; CONTROLLED STUDY; DISEASE MODEL; DOG; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR XENOGRAFT;

EID: 70449724951     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-363     Document Type: Article

References (68)

1. Pawlik TM, Paulino AF, McGinn CJ, Baker LH, Cohen DS, Morris JS, Rees R, Sondak VK. Cutaneous angiosarcoma of the scalp: a multidisciplinary approach. Cancer 2003, 98:1716-1726. 10.1002/cncr.11667, 14534889.
2. Mark RJ, Tran LM, Sercarz J, Fu YS, Calcaterra TC, Juillard GF. Angiosarcoma of the head and neck. The UCLA experience 1955 through 1990. Arch Otolaryngol Head Neck Surg 1993, 119:973-978.
3. Mark RJ, Poen JC, Tran LM, Fu YS, Juillard GF. Angiosarcoma. A report of 67 patients and a review of the literature. Cancer 1996, 77:2400-2406. 10.1002/(SICI)1097-0142(19960601)77:11<2400::AID-CNCR32>3.0.CO;2-Z, 8635113.
4. Abraham JA, Hornicek FJ, Kaufman AM, Harmon DC, Springfield DS, Raskin KA, Mankin HJ, Kirsch DG, Rosenberg AE, Nielsen GP. Treatment and outcome of 82 patients with angiosarcoma. Ann Surg Oncol 2007, 14:1953-1967. 10.1245/s10434-006-9335-y, 17356953.
5. Thamm DH. Miscellaneous Tumors. Withrow and Macewen's Small Animal Clinical Oncology 2007, 785-794. St. Louis: Saunders, Withrow SJ, Vail DM, Fourth.
6. Murakami M, Sakai H, Kodama A, Mori T, Maruo K, Yanai T, Masegi T. Expression of the anti-apoptotic factors Bcl-2 and survivin in canine vascular tumours. J Comp Pathol 2008, 139:1-7. 10.1016/j.jcpa.2008.02.001, 18479697.
7. Murakami M, Sakai H, Kodama A, Yanai T, Mori T, Maruo K, Masegi T. Activation of matrix metalloproteinase (MMP)-2 by membrane type 1-MMP and abnormal immunolocalization of the basement membrane components laminin and type IV collagen in canine spontaneous hemangiosarcomas. Histol Histopathol 2009, 24:437-446.
8. Yonemaru K, Sakai H, Murakami M, Kodama A, Mori T, Yanai T, Maruo K, Masegi T. The significance of p53 and retinoblastoma pathways in canine hemangiosarcoma. J Vet Med Sci 2007, 69:271-278. 10.1292/jvms.69.271, 17409643.
9. Itakura E, Yamamoto H, Oda Y, Tsuneyoshi M. Detection and characterization of vascular endothelial growth factors and their receptors in a series of angiosarcomas. J Surg Oncol 2008, 97:74-81. 10.1002/jso.20766, 18041747.
10. Yonemaru K, Sakai H, Murakami M, Yanai T, Masegi T. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and their receptors (flt-1, flk-1, and flg-1) in canine vascular tumors. Vet Pathol 2006, 43:971-980. 10.1354/vp.43-6-971, 17099154.
11. Deschamps J, Meijlink F. Mammalian homeobox genes in normal development and neoplasia. Crit Rev Oncog 1992, 3:117-173.
12. Mavilio F. Regulation of vertebrate homeobox-containing genes by morphogens. Eur J Biochem 1993, 212:273-288. 10.1111/j.1432-1033.1993.tb17660.x, 8095237.
13. Bruhl T, Urbich C, Aicher D, Acker-Palmer A, Zeiher AM, Dimmeler S. Homeobox A9 transcriptionally regulates the EphB4 receptor to modulate endothelial cell migration and tube formation. Circ Res 2004, 94:743-751. 10.1161/01.RES.0000120861.27064.09, 14764452.
14. Myers C, Charboneau A, Boudreau N. Homeobox B3 promotes capillary morphogenesis and angiogenesis. J Cell Biol 2000, 148:343-351. 10.1083/jcb.148.2.343, 2174277, 10648567.
15. Ohta H, Hamada J, Tada M, Aoyama T, Furuuchi K, Takahashi Y, Totsuka Y, Moriuchi T. HOXD3-overexpression increases integrin alpha v beta 3 expression and deprives E-cadherin while it enhances cell motility in A549 cells. Clin Exp Metastasis 2006, 23:381-390. 10.1007/s10585-006-9047-5, 17187229.
16. Charboneau A, East L, Mulholland N, Rohde M, Boudreau N. Pbx1 is required for Hox D3-mediated angiogenesis. Angiogenesis 2005, 8:289-296. 10.1007/s10456-005-9016-7, 16328158.
17. Boudreau N, Andrews C, Srebrow A, Ravanpay A, Cheresh DA. Induction of the angiogenic phenotype by Hox D3. J Cell Biol 1997, 139:257-264. 10.1083/jcb.139.1.257, 2139816, 9314544.
18. Gehring WJ, Hiromi Y. Homeotic genes and the homeobox. Annu Rev Genet 1986, 20:147-173. 10.1146/annurev.ge.20.120186.001051, 2880555.
19. Thamm DH, Dickerson EB, Akhtar N, Lewis R, Auerbach R, Helfand SC, MacEwen EG. Biological and molecular characterization of a canine hemangiosarcoma-derived cell line. Res Vet Sci 2006, 81:76-86. 10.1016/j.rvsc.2005.09.005, 16256156.
20. Fosmire SP, Dickerson EB, Scott AM, Bianco SR, Pettengill MJ, Meylemans H, Padilla M, Frazer-Abel AA, Akhtar N, Getzy DM. Canine malignant hemangiosarcoma as a model of primitive angiogenic endothelium. Lab Invest 2004, 84:562-572. 10.1038/labinvest.3700080, 15064773.
21. Kobie K, Kawabata M, Hioki K, Tanaka A, Matsuda H, Mori T, Maruo K. The tyrosine kinase inhibitor imatinib [STI571] induces regression of xenografted canine mast cell tumors in SCID mice. Res Vet Sci 2007, 82:239-241. 10.1016/j.rvsc.2006.06.006, 16919303.
22. Akhtar N, Padilla ML, Dickerson EB, Steinberg H, Breen M, Auerbach R, Helfand SC. Interleukin-12 inhibits tumor growth in a novel angiogenesis canine hemangiosarcoma xenograft model. Neoplasia 2004, 6:106-116. 10.1593/neo.03334, 1502086, 15140399.
23. Jin I, Yuji M, Yoshinori N, Makoto K, Mikio M. Anti-tumor effect of PDT using Photofrin in a mouse angiosarcoma model. Arch Dermatol Res 2008, 300:161-166. 10.1007/s00403-007-0820-3, 18080130.
24. Ferrer L, Fondevila D, Rabanal RM, Vilafranca M. Immunohistochemical detection of CD31 antigen in normal and neoplastic canine endothelial cells. J Comp Pathol 1995, 112:319-326. 10.1016/S0021-9975(05)80013-1, 7593754.
25. von Beust BR, Suter MM, Summers BA. Factor VIII-related antigen in canine endothelial neoplasms: an immunohistochemical study. Vet Pathol 1988, 25:251-255.
26. Kodama A, Sakai H, Kobayashi K, Mori T, Maruo K, Kudo T, Yanai T, Masegi T. B-cell intestinal lymphoma with Mott cell differentiation in a 1-year-old miniature Dachshund. Vet Clin Pathol 2008, 37:409-415. 10.1111/j.1939-165X.2008.00067.x, 19055576.
27. Kodama A, Sakai H, Murakami M, Murai A, Mori T, Maruo K, Yanai T, Masegi T. Immunohistochemical Demonstration of Angiogenesis-Associated Homeobox Proteins in Canine Vascular Tumours. J Comp Pathol 2009, 141:199-203. 10.1016/j.jcpa.2009.04.004, 19505696.
28. Azcoitia V, Aracil M, Martinez AC, Torres M. The homeodomain protein Meis1 is essential for definitive hematopoiesis and vascular patterning in the mouse embryo. Dev Biol 2005, 280:307-320. 10.1016/j.ydbio.2005.01.004, 15882575.
29. Birner P, Ritzi M, Musahl C, Knippers R, Gerdes J, Voigtlander T, Budka H, Hainfellner JA. Immunohistochemical detection of cell growth fraction in formalin-fixed and paraffin-embedded murine tissue. Am J Pathol 2001, 158:1991-1996. 1891991, 11395376.
30. Stephen J, Withrow DMV, . (ed) Withrow and Macewen's Small Animal Clinical Oncology. 2007, St. Louis, Missouri: Saunders, an imprint of Elsevier Inc, Fourth.
31. Uchida N, Nagai K, Sakurada Y, Shirota K. The expression of VEGF and flt-1 in the Normal Dog tissues. J Vet Med Sci 2008, 70:1273-1276. 10.1292/jvms.70.1273, 19057151.
32. Stalmans I. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome. Verh K Acad Geneeskd Belg 2005, 67:229-276.
33. Lee YH, Tokunaga T, Oshika Y, Suto R, Yanagisawa K, Tomisawa M, Fukuda H, Nakano H, Abe S, Tateishi A. Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma. Eur J Cancer 1999, 35:1089-1093. 10.1016/S0959-8049(99)00073-8, 10533453.
34. Tomisawa M, Tokunaga T, Oshika Y, Tsuchida T, Fukushima Y, Sato H, Kijima H, Yamazaki H, Ueyama Y, Tamaoki N. Expression pattern of vascular endothelial growth factor isoform is closely correlated with tumour stage and vascularisation in renal cell carcinoma. Eur J Cancer 1999, 35:133-137. 10.1016/S0959-8049(98)00278-0, 10211101.
35. Oshika Y, Nakamura M, Tokunaga T, Ozeki Y, Fukushima Y, Hatanaka H, Abe Y, Yamazaki H, Kijima H, Tamaoki N. Expression of cell-associated isoform of vascular endothelial growth factor 189 and its prognostic relevance in non-small cell lung cancer. Int J Oncol 1998, 12:541-544.
36. Yuan A, Yu CJ, Chen WJ, Lin FY, Kuo SH, Luh KT, Yang PC. Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer. Int J Cancer 2000, 89:475-483. 10.1002/1097-0215(20001120)89:6<475::AID-IJC2>3.0.CO;2-T, 11102890.
37. Yuan A, Yu CJ, Kuo SH, Chen WJ, Lin FY, Luh KT, Yang PC, Lee YC. Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer. J Clin Oncol 2001, 19:432-441.
38. Tokunaga T, Oshika Y, Abe Y, Ozeki Y, Sadahiro S, Kijima H, Tsuchida T, Yamazaki H, Ueyama Y, Tamaoki N. Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer. Br J Cancer 1998, 77:998-1002. 2150098, 9528847.
39. Gasparini G. Prognostic value of vascular endothelial growth factor in breast cancer. Oncologist 2000, 5(Suppl 1):37-44. 10.1634/theoncologist.5-suppl_1-37, 10804090.
40. Hashimoto M, Ohsawa M, Ohnishi A, Naka N, Hirota S, Kitamura Y, Aozasa K. Expression of vascular endothelial growth factor and its receptor mRNA in angiosarcoma. Lab Invest 1995, 73:859-863.
41. Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg AM, Sauvageau G. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. Embo J 1998, 17:3714-3725. 10.1093/emboj/17.13.3714, 1170707, 9649441.
42. Steinle JJ, Meininger CJ, Forough R, Wu G, Wu MH, Granger HJ. Eph B4 receptor signaling mediates endothelial cell migration and proliferation via the phosphatidylinositol 3-kinase pathway. J Biol Chem 2002, 277:43830-43835. 10.1074/jbc.M207221200, 12235151.
43. Thorsteinsdottir U, Mamo A, Kroon E, Jerome L, Bijl J, Lawrence HJ, Humphries K, Sauvageau G. Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion. Blood 2002, 99:121-129. 10.1182/blood.V99.1.121, 11756161.
44. Boudreau NJ, Varner JA. The homeobox transcription factor Hox D3 promotes integrin alpha5beta1 expression and function during angiogenesis. J Biol Chem 2004, 279:4862-4868. 10.1074/jbc.M305190200, 14610084.
45. Hansen SL, Dosanjh A, Young DM, Boudreau N, Hoffman WY. Hemangiomas and homeobox gene expression. J Craniofac Surg 2006, 17:767-771. 10.1097/00001665-200607000-00031, 16877932.
46. Care A, Felicetti F, Meccia E, Bottero L, Parenza M, Stoppacciaro A, Peschle C, Colombo MP. HOXB7: a key factor for tumor-associated angiogenic switch. Cancer Res 2001, 61:6532-6539.
47. Krosl J, Baban S, Krosl G, Rozenfeld S, Largman C, Sauvageau G. Cellular proliferation and transformation induced by HOXB4 and HOXB3 proteins involves cooperation with PBX1. Oncogene 1998, 16:3403-3412. 10.1038/sj.onc.1201883, 9692548.
48. Shiraishi K, Yamasaki K, Nanba D, Inoue H, Hanakawa Y, Shirakata Y, Hashimoto K, Higashiyama S. Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression. Oncogene 2007, 26:339-348. 10.1038/sj.onc.1209800, 16862184.
49. Crijns AP, de Graeff P, Geerts D, Ten Hoor KA, Hollema H, Sluis T, Hofstra RM, de Bock GH, de Jong S, Zee AG. MEIS and PBX homeobox proteins in ovarian cancer. Eur J Cancer 2007, 43:2495-2505. 10.1016/j.ejca.2007.08.025, 17949970.
50. Puppin C, Puglisi F, Pellizzari L, Manfioletti G, Pestrin M, Pandolfi M, Piga A, Di Loreto C, Damante G. HEX expression and localization in normal mammary gland and breast carcinoma. BMC Cancer 2006, 6:192. 10.1186/1471-2407-6-192, 1550255, 16854221.
51. D'Elia AV, Tell G, Russo D, Arturi F, Puglisi F, Manfioletti G, Gattei V, Mack DL, Cataldi P, Filetti S. Expression and localization of the homeodomain-containing protein HEX in human thyroid tumors. J Clin Endocrinol Metab 2002, 87:1376-1383. 10.1210/jc.87.3.1376, 11889211.
52. Tiberio C, Barba P, Magli MC, Arvelo F, Le Chevalier T, Poupon MF, Cillo C. HOX gene expression in human small-cell lung cancers xenografted into nude mice. Int J Cancer 1994, 58:608-615. 10.1002/ijc.2910580426, 7914516.
53. Buzzai M, Licht JD. New molecular concepts and targets in acute myeloid leukemia. Curr Opin Hematol 2008, 15:82-87. 10.1097/MOH.0b013e3282f3ded0, 18300752.
54. Reddy SD, Ohshiro K, Rayala SK, Kumar R. MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions. Cancer Res 2008, 68:8195-8200. 10.1158/0008-5472.CAN-08-2103, 18922890.
55. Zhang X, Zhu T, Chen Y, Mertani HC, Lee KO, Lobie PE. Human growth hormone-regulated HOXA1 is a human mammary epithelial oncogene. J Biol Chem 2003, 278:7580-7590. 10.1074/jbc.M212050200, 12482855.
56. Plowright L, Harrington KJ, Pandha HS, Morgan R. HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer). Br J Cancer 2009, 100:470-475. 10.1038/sj.bjc.6604857, 19156136.
57. Furukawa T, Kubota T, Watanabe M, Nishibori H, Kuo TH, Saikawa Y, Kase S, Tanino H, Teramoto T, Ishibiki K. A suitable model for experimental liver metastasis of human colon cancer xenografts using mice with severe combined immunodeficiency. J Surg Oncol 1993, 52:64-67. 10.1002/jso.2930520117, 8441264.
58. Nomura T, Takahama Y, Hongyo T, Inohara H, Takatera H, Fukushima H, Ishii Y, Hamaoka T. SCID (severe combined immunodeficiency) mice as a new system to investigate metastasis of human tumors. J Radiat Res (Tokyo) 1990, 31:288-292. 10.1269/jrr.31.288, 2246754.
59. Garofalo A, Chirivi RG, Scanziani E, Mayo JG, Vecchi A, Giavazzi R. Comparative study on the metastatic behavior of human tumors in nude, beige/nude/xid and severe combined immunodeficient mice. Invasion Metastasis 1993, 13:82-91.
60. Fidler IJ. Orthotopic implantation of human colon carcinomas into nude mice provides a valuable model for the biology and therapy of metastasis. Cancer Metastasis Rev 1991, 10:229-243. 10.1007/BF00050794, 1764766.
61. Morikawa K, Walker SM, Nakajima M, Pathak S, Jessup JM, Fidler IJ. Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res 1988, 48:6863-6871.
62. Naito S, von Eschenbach AC, Fidler IJ. Different growth pattern and biologic behavior of human renal cell carcinoma implanted into different organs of nude mice. J Natl Cancer Inst 1987, 78:377-385.
63. Ohguri T, Imada H, Nomoto S, Yahara K, Hisaoka M, Hashimoto H, Tokura Y, Nakamura K, Shioyama Y, Honda H. Angiosarcoma of the scalp treated with curative radiotherapy plus recombinant interleukin-2 immunotherapy. Int J Radiat Oncol Biol Phys 2005, 61:1446-1453.
64. Wollina U, Fuller J, Graefe T, Kaatz M, Lopatta E. Angiosarcoma of the scalp: treatment with liposomal doxorubicin and radiotherapy. J Cancer Res Clin Oncol 2001, 127:396-399. 10.1007/s004320000221, 11414200.
65. Ulrich L, Krause M, Brachmann A, Franke I, Gollnick H. Successful treatment of angiosarcoma of the scalp by intralesional cytokine therapy and surface irradiation. J Eur Acad Dermatol Venereol 2000, 14:412-415. 10.1046/j.1468-3083.2000.00111.x, 11305388.
66. Taylor KL, Oates RK, Grane R, Leaman DW, Borden EC, Lindner DJ. IFN-alpha1,8 inhibits tumor-induced angiogenesis in murine angiosarcomas. J Interferon Cytokine Res 2006, 26:353-361. 10.1089/jir.2006.26.353, 16689662.
67. Ma G, Masuzawa M, Hamada Y, Haraguchi F, Tamauchi H, Sakurai Y, Fujimura T, Katsuoka K. Treatment of murine angiosarcoma with etoposide, TNP-470 and prednisolone. J Dermatol Sci 2000, 24:126-133. 10.1016/S0923-1811(00)00089-X, 11064248.
68. Vogt T, Hafner C, Bross K, Bataille F, Jauch KW, Berand A, Landthaler M, Andreesen R, Reichle A. Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumors. Cancer 2003, 98:2251-2256. 10.1002/cncr.11775, 14601096.